Evidence map›Paper›PMID 42897841›Full record

ArticleEpilepsia open2026

Early neurocognitive outcomes following SEEG with radiofrequency thermocoagulation.

Emily Cockle, Charles B Malpas, Honor Coleman, Alissandra McIlroy, Joshua Laing, Martin Hunn, Matthew Gutman, Stacey Logan, Georgia-Rose Robinson, Cecilia Harb and 9 more

Abstract read
In one paragraph

Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Emily CockleDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-3289-2181
Charles B MalpasDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-0534-3718
Honor ColemanDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-5532-9327
Alissandra McIlroyDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Joshua LaingDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Martin HunnDepartment of Neurosurgery, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Matthew GutmanDepartment of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
Stacey LoganMelbourne School of Psychological Sciences, University of Melbourne, Parkville, Victoria, Australia.
Georgia-Rose RobinsonMelbourne School of Psychological Sciences, University of Melbourne, Parkville, Victoria, Australia.
Cecilia HarbDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Catherine MeadeDepartment of Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
Wendyl D'SouzaDepartment of Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
Amy HallidayDepartment of Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
Kristian BullussDepartment of Neurosurgery, St Vincent's Hospital, Melbourne, Victoria, Australia.
Simon VogrinDepartment of Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
Rubina AlpitsisDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Terence J O'BrienDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.
Genevieve RaynerDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-0747-3877
Andrew NealDepartment of Neurology, Alfred Hospital, Bayside Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-9251-5471

Funding

Australian Epilepsy Research FundNational Health and Medical Research Council APP1176426National Health and Medical Research Council APP2008737National Health and Medical Research Council APP2009152
6 · The paper itself

Abstract

objectiveCharacterization of early neuropsychological outcomes following SEEG with radiofrequency thermocoagulation (RFTHC) is essential to guide patient expectations around return to work, study, and caregiving. The current study aimed to describe the early neurocognitive sequelae of SEEG.

methodsConsecutive patients undergoing SEEG were prospectively recruited from two tertiary epilepsy centers in Melbourne, Australia. Patients were administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) via telehealth before and 3 weeks after SEEG (M = 19.69 days, SD = 4.41). Given the telehealth platform, the coding subtest was substituted for the Symbol Digit Modalities Test, and a modified score of global cognitive function was calculated. To evaluate group changes, paired sample t-tests were performed. Reliable change indices were computed to explore individual-level changes. Pearson's correlation coefficients evaluated relationships between change in global cognitive function and SEEG admission variables. SEEG patients were invited to complete a semi-structured interview canvassing the recovery following SEEG.

resultsTwenty-eight patients completed the neuropsychological examination (M = 37.89 years, SD = 9.72, range = 17-56 years, 54% female). All patients underwent RFTHC with a mean of 11.43 (SD = 6.87, range = 2-28) coagulation sites. At a whole group level, 3-weeks post SEEG there was no evidence for global nor domain-specific cognitive change. Reliable change indices with 90% confidence revealed only 4% (1/28) declined on at least two measures and 10% (3/28) showed psychometric improvement. Pearson's correlational coefficients showed no evidence for association between change in global cognitive function with SEEG factors including admission length, number of spontaneous or stimulated seizures, number of electrodes, or number of RFTHC sites. Subjective reports of language change tended to be accompanied by a decline on the RBANS language index that did not meet reliable change criteria. Most patients reported returning to work around 4 weeks post SEEG. SIGNIFICANCE: By 3 weeks, gross cognitive functioning tends to be in keeping with pre-SEEG performances for most patients. These findings have direct clinical implications for SEEG neuropsychological counseling. PLAIN LANGUAGE STATEMENT: SEEG is increasingly used to guide epilepsy surgery. Despite this, little is known about the cognitive recovery in the weeks following the procedure. We found that for most patients, broad cognitive functioning 3 weeks after SEEG with coagulation was consistent with function before SEEG, with only a small minority showing significant changes. Some people who reported language difficulties also showed a decline on language testing, although this was often small. Of those patients working before SEEG, most returned to work by 4 weeks. These results provide important evidence to guide patient counseling, recovery planning, and management after SEEG.

Indexed as

cognitive recoveryneuropsychologyRFTHCstereo‐EEG

Identifiers

PMID42897841
PMCPMC13680816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.